Q32 Bio Inc. (QTTB) Long-Term Investments (2022 - 2025)

Q32 Bio has reported Long-Term Investments for 4 years, with the latest figure at $2.5 million in Q1 2025.

• On a quarterly basis, Long-Term Investments fell 46.53% year-over-year to $2.5 million in Q1 2025; TTM through Mar 2025 was $2.5 million, a 46.53% decrease from a year earlier, with the FY2024 full-year figure at $2.6 million, changed N/A from the prior year.
• Long-Term Investments was $2.5 million for Q1 2025 at Q32 Bio, down from $2.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $30.6 million in Q1 2022, with the low at $2.5 million in Q1 2025.
• Average Long-Term Investments over 4 years is $15.2 million, with a median of $15.7 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Long-Term Investments retreated 24.81% in 2023, then plunged 81.43% in 2024.
• Over 4 years, Long-Term Investments stood at $25.8 million in 2022, then slumped by 45.77% to $14.0 million in 2023, then slumped by 81.43% to $2.6 million in 2024, then decreased by 2.85% to $2.5 million in 2025.
• The last three Long-Term Investments figures came in at $2.5 million (Q1 2025), $2.6 million (Q4 2024), and $2.6 million (Q3 2024), per Business Quant data.